
Today's discussion
Infinity Peptides
We will discuss the preclinical trial information on Bpc157 what have we heard what have we experienced, along with where does it come from. ‘RSSVERIFY’
番組について
We will discuss the preclinical trial information on Bpc157 what have we heard what have we experienced, along with where does it come from.
‘RSSVERIFY’
情報
- クリエイターInfinity Peptides
- 配信期間25年 - 26年
- エピソード74
- 制限指定不適切な内容を含まない
- Copyright© Infinity Premier Consulting LLC
- 番組のWebサイト